Claussnitzer et al. performed studies in adipocytes of lean adult humans and delineated the activation of two genes near the FTO locus, IRX3 and IRX5, during early adipocyte differentiation as a new mechanism conferring genetic obesity risk whereby variants in FTO directly affect adipocyte function [9]. The gene discussed is IRX5; the disease is Genetic obesity.